Chicago Capital, LLC Viatris Inc Transaction History

Chicago Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$8.48 - $11.13 $3,434 - $4,507	-405 Reduced 3.83%	10,167 $87,000
Q2 2022 Jul 21, 2022	SELL	$9.95 - $12.27 $318 - $392	-32 Reduced 0.3%	10,572 $111,000
Q1 2022 Apr 21, 2022	SELL	$9.81 - $15.4 $8,966 - $14,075	-914 Reduced 7.94%	10,604 $115,000
Q4 2021 Jan 20, 2022	SELL	$12.09 - $14.68 $7,652 - $9,292	-633 Reduced 5.21%	11,518 $156,000
Q3 2021 Oct 28, 2021	SELL	$13.25 - $15.13 $1,987 - $2,269	-150 Reduced 1.22%	12,151 $165,000
Q2 2021 Jul 22, 2021	SELL	$12.97 - $16.15 $1,245 - $1,550	-96 Reduced 0.77%	12,301 $176,000
Q1 2021 Apr 13, 2021	SELL	$13.59 - $18.54 $12,298 - $16,778	-905 Reduced 6.8%	12,397 $173,000
Q4 2020 Jan 25, 2021	BUY	$14.3 - $18.74 $190,218 - $249,279	13,302 New	13,302 $249,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Capital, LLC with notifications on news.